NCT01876511 · ADVERSE EVENTS
Adverse events
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
Adverse events occurred during the study; they are not necessarily caused by treatment. Serious events are not interchangeable with severe/grade 3–4 events. These safety populations may differ from efficacy populations.
- Collection time frame
- 2 years 4 months Study treatment was administered for up to 2 years. Adverse events were accessed through 90 days after the last dose of study treatment.
- Other-event reporting threshold
- 5%
| Safety group | Serious events | Other events | Deaths |
|---|---|---|---|
| Cohort A: MSI Positive Colorectal Cancer | 4 / 41 | 41 / 41 | 3 / 41 |
| Cohort B: MSI Negative Colorectal Cancer | 0 / 25 | 3 / 25 | 0 / 25 |
| Cohort C: MSI Positive Non-Colorectal Cancer | 7 / 47 | 47 / 47 | 2 / 47 |
Serious adverse events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Renal and urinary disorders
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 41
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 25
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 47
- num Events
- 0
- term
- Acute kidney injury
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Musculoskeletal and connective tissue disorders
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 41
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 25
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 47
- num Events
- 0
- term
- Arthritis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 41
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 25
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 47
- num Events
- 1
- term
- Pancreatitis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 41
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 25
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 47
- num Events
- 1
- term
- Diarrhea
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 41
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 25
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 47
- num Events
- 1
- term
- Colitis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Cardiac disorders
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 41
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 25
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 47
- num Events
- 1
- term
- Myocarditis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Metabolism and nutrition disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 41
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 25
- num Events
- 0
- group Id
- EG002
- num Affected
- 2
- num At Risk
- 47
- num Events
- 2
- term
- Diabetic ketoacidosis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Product Issues
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 41
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 25
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 47
- num Events
- 0
- term
- Infusion reaction
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Nervous system disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 41
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 25
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 47
- num Events
- 1
- term
- Neuropathy
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 41
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 25
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 47
- num Events
- 0
- term
- Cellulitis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Hepatobiliary disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 41
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 25
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 47
- num Events
- 1
- term
- Alanine aminotransferase Increased (ALT)
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Hepatobiliary disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 41
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 25
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 47
- num Events
- 1
- term
- Aspartate aminotransferase increased (AST)
Other reported adverse events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- stats
- group Id
- EG000
- num Affected
- 3
- num At Risk
- 41
- num Events
- 3
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 25
- num Events
- 0
- group Id
- EG002
- num Affected
- 4
- num At Risk
- 47
- num Events
- 4
- term
- Anemia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Endocrine disorders
- stats
- group Id
- EG000
- num Affected
- 6
- num At Risk
- 41
- num Events
- 6
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 25
- num Events
- 0
- group Id
- EG002
- num Affected
- 13
- num At Risk
- 47
- num Events
- 13
- term
- Hypothyroidism/thyroiditis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- stats
- group Id
- EG000
- num Affected
- 10
- num At Risk
- 41
- num Events
- 10
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 25
- num Events
- 0
- group Id
- EG002
- num Affected
- 9
- num At Risk
- 47
- num Events
- 9
- term
- Diarrhea
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- stats
- group Id
- EG000
- num Affected
- 5
- num At Risk
- 41
- num Events
- 5
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 25
- num Events
- 0
- group Id
- EG002
- num Affected
- 8
- num At Risk
- 47
- num Events
- 8
- term
- Nausea
- assessment Type
- SYSTEMATIC_ASSESSMENT
- notes
- and administration site conditions
- organ System
- General disorders
- stats
- group Id
- EG000
- num Affected
- 8
- num At Risk
- 41
- num Events
- 8
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 25
- num Events
- 1
- group Id
- EG002
- num Affected
- 13
- num At Risk
- 47
- num Events
- 13
- term
- Fatigue
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Investigations
- stats
- group Id
- EG000
- num Affected
- 3
- num At Risk
- 41
- num Events
- 3
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 25
- num Events
- 0
- group Id
- EG002
- num Affected
- 3
- num At Risk
- 47
- num Events
- 3
- term
- Alanine aminotransferase Increased (ALT)
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Investigations
- stats
- group Id
- EG000
- num Affected
- 4
- num At Risk
- 41
- num Events
- 4
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 25
- num Events
- 0
- group Id
- EG002
- num Affected
- 5
- num At Risk
- 47
- num Events
- 5
- term
- Aspartate aminotransferase increased (AST)
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Investigations
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 41
- num Events
- 2
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 25
- num Events
- 0
- group Id
- EG002
- num Affected
- 5
- num At Risk
- 47
- num Events
- 5
- term
- Lymphocyte count decreased
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Investigations
- stats
- group Id
- EG000
- num Affected
- 3
- num At Risk
- 41
- num Events
- 3
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 25
- num Events
- 0
- group Id
- EG002
- num Affected
- 3
- num At Risk
- 47
- num Events
- 3
- term
- White blood cell decreased
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Musculoskeletal and connective tissue disorders
- stats
- group Id
- EG000
- num Affected
- 7
- num At Risk
- 41
- num Events
- 7
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 25
- num Events
- 0
- group Id
- EG002
- num Affected
- 4
- num At Risk
- 47
- num Events
- 4
- term
- Arthralgia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Nervous system disorders
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 41
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 25
- num Events
- 0
- group Id
- EG002
- num Affected
- 5
- num At Risk
- 47
- num Events
- 5
- term
- Neuropathy
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Skin and subcutaneous tissue disorders
- stats
- group Id
- EG000
- num Affected
- 6
- num At Risk
- 41
- num Events
- 6
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 25
- num Events
- 0
- group Id
- EG002
- num Affected
- 13
- num At Risk
- 47
- num Events
- 13
- term
- Pruritus
Complete source fields
- event Groups
- deaths Num Affected
- 3
- deaths Num At Risk
- 41
- description
- MK-3475: MK-3475 10 mg/kg every 14 days
- id
- EG000
- other Num Affected
- 41
- other Num At Risk
- 41
- serious Num Affected
- 4
- serious Num At Risk
- 41
- title
- Cohort A: MSI Positive Colorectal Cancer
- deaths Num Affected
- 0
- deaths Num At Risk
- 25
- description
- MK-3475: MK-3475 10 mg/kg every 14 days
- id
- EG001
- other Num Affected
- 3
- other Num At Risk
- 25
- serious Num Affected
- 0
- serious Num At Risk
- 25
- title
- Cohort B: MSI Negative Colorectal Cancer
- deaths Num Affected
- 2
- deaths Num At Risk
- 47
- description
- MK-3475: MK-3475 10 mg/kg every 14 days
- id
- EG002
- other Num Affected
- 47
- other Num At Risk
- 47
- serious Num Affected
- 7
- serious Num At Risk
- 47
- title
- Cohort C: MSI Positive Non-Colorectal Cancer
- frequency Threshold
- 5
- other Events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- stats
- group Id
- EG000
- num Affected
- 3
- num At Risk
- 41
- num Events
- 3
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 25
- num Events
- 0
- group Id
- EG002
- num Affected
- 4
- num At Risk
- 47
- num Events
- 4
- term
- Anemia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Endocrine disorders
- stats
- group Id
- EG000
- num Affected
- 6
- num At Risk
- 41
- num Events
- 6
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 25
- num Events
- 0
- group Id
- EG002
- num Affected
- 13
- num At Risk
- 47
- num Events
- 13
- term
- Hypothyroidism/thyroiditis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- stats
- group Id
- EG000
- num Affected
- 10
- num At Risk
- 41
- num Events
- 10
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 25
- num Events
- 0
- group Id
- EG002
- num Affected
- 9
- num At Risk
- 47
- num Events
- 9
- term
- Diarrhea
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- stats
- group Id
- EG000
- num Affected
- 5
- num At Risk
- 41
- num Events
- 5
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 25
- num Events
- 0
- group Id
- EG002
- num Affected
- 8
- num At Risk
- 47
- num Events
- 8
- term
- Nausea
- assessment Type
- SYSTEMATIC_ASSESSMENT
- notes
- and administration site conditions
- organ System
- General disorders
- stats
- group Id
- EG000
- num Affected
- 8
- num At Risk
- 41
- num Events
- 8
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 25
- num Events
- 1
- group Id
- EG002
- num Affected
- 13
- num At Risk
- 47
- num Events
- 13
- term
- Fatigue
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Investigations
- stats
- group Id
- EG000
- num Affected
- 3
- num At Risk
- 41
- num Events
- 3
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 25
- num Events
- 0
- group Id
- EG002
- num Affected
- 3
- num At Risk
- 47
- num Events
- 3
- term
- Alanine aminotransferase Increased (ALT)
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Investigations
- stats
- group Id
- EG000
- num Affected
- 4
- num At Risk
- 41
- num Events
- 4
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 25
- num Events
- 0
- group Id
- EG002
- num Affected
- 5
- num At Risk
- 47
- num Events
- 5
- term
- Aspartate aminotransferase increased (AST)
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Investigations
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 41
- num Events
- 2
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 25
- num Events
- 0
- group Id
- EG002
- num Affected
- 5
- num At Risk
- 47
- num Events
- 5
- term
- Lymphocyte count decreased
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Investigations
- stats
- group Id
- EG000
- num Affected
- 3
- num At Risk
- 41
- num Events
- 3
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 25
- num Events
- 0
- group Id
- EG002
- num Affected
- 3
- num At Risk
- 47
- num Events
- 3
- term
- White blood cell decreased
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Musculoskeletal and connective tissue disorders
- stats
- group Id
- EG000
- num Affected
- 7
- num At Risk
- 41
- num Events
- 7
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 25
- num Events
- 0
- group Id
- EG002
- num Affected
- 4
- num At Risk
- 47
- num Events
- 4
- term
- Arthralgia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Nervous system disorders
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 41
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 25
- num Events
- 0
- group Id
- EG002
- num Affected
- 5
- num At Risk
- 47
- num Events
- 5
- term
- Neuropathy
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Skin and subcutaneous tissue disorders
- stats
- group Id
- EG000
- num Affected
- 6
- num At Risk
- 41
- num Events
- 6
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 25
- num Events
- 0
- group Id
- EG002
- num Affected
- 13
- num At Risk
- 47
- num Events
- 13
- term
- Pruritus
- serious Events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Renal and urinary disorders
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 41
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 25
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 47
- num Events
- 0
- term
- Acute kidney injury
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Musculoskeletal and connective tissue disorders
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 41
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 25
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 47
- num Events
- 0
- term
- Arthritis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 41
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 25
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 47
- num Events
- 1
- term
- Pancreatitis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 41
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 25
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 47
- num Events
- 1
- term
- Diarrhea
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 41
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 25
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 47
- num Events
- 1
- term
- Colitis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Cardiac disorders
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 41
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 25
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 47
- num Events
- 1
- term
- Myocarditis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Metabolism and nutrition disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 41
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 25
- num Events
- 0
- group Id
- EG002
- num Affected
- 2
- num At Risk
- 47
- num Events
- 2
- term
- Diabetic ketoacidosis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Product Issues
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 41
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 25
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 47
- num Events
- 0
- term
- Infusion reaction
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Nervous system disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 41
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 25
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 47
- num Events
- 1
- term
- Neuropathy
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 41
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 25
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 47
- num Events
- 0
- term
- Cellulitis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Hepatobiliary disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 41
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 25
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 47
- num Events
- 1
- term
- Alanine aminotransferase Increased (ALT)
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Hepatobiliary disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 41
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 25
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 47
- num Events
- 1
- term
- Aspartate aminotransferase increased (AST)
- time Frame
- 2 years 4 months Study treatment was administered for up to 2 years. Adverse events were accessed through 90 days after the last dose of study treatment.
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Independent clinical review pending · Not medical advice
Triangle